Released on = January 17, 2007, 4:08 pm

Press Release Author = GTCbio

Industry = Biotech

Press Release Summary = Bioshield has been in place for a 18 months. What progress
has been made in the effort to protect Americans from potential chemical,
biological, radiological or nuclear (CBRN) attacks? Experts will discuss this issue
in a panel entitled, "The Progress of Bioshield".

Press Release Body = MONROVIA, CA - The Project BioShield Act was unanimously
approved by the Senate, and signed by President Bush in July 2004. The measure was
a response to the threat of a potential chemical, biological, radiological or
nuclear (CBRN) attack on America. At an upcoming meeting in San Francisco, 4
experts will examine the performance of this program for the year and a half since
it has been enacted.

Clem Lewin, Vice President of Biodefense and Policy for Acambis will moderate a
sixty minute panel entitled, "The Progress of Bioshield". He will be joined by
panelists Piers Whitehead (Vice President of Corporate and Business Development for
VaxGen), Beth Seidenberg (Executive in Residence at Kleiner Perkins Caufield &
Byers) and Chris Colwell (Director of Vaccines Policy for BIO).

"The Progress of Bioshield" is a part of the the 4th Anti-Infectives Partnering &
Deal-Making Summit taking place on January 25-26, 2007 in San Francisco, California.
Other topics to be covered include the Future of Partnering in Infectious Diseases,
Big Pharma Spin offs, Re-emerging Pathogens, Novel Anti-Infectives and more. For
more additional details, visit www.gtcbio.com.

ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical
industries. Our goal is to facilitate the exchange of biopharmaceutical and
biomedical intelligence between industry leaders, academic and government
organizations, and the financial community.

GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company
founded in 2002.


Web Site = http://www.gtcbio.com

Contact Details =
For more information contact Christy Bowman at GTCbio. Phone: (626) 256-6405 x101,
Fax: (626) 256-6460, Email: Christy.bowman@gtcbio.com